Endoscopic resection of giant gastrointestinal stromal tumor at the esophagogastric junction: a case report
- PMID: 31881944
- PMCID: PMC6935202
- DOI: 10.1186/s12876-019-1151-5
Endoscopic resection of giant gastrointestinal stromal tumor at the esophagogastric junction: a case report
Abstract
Background: Gastrointestinal stromal tumors (GISTs) at the esophagogastric junction are rare and its treatment is complicated and challenging. Endoscopic resection has advantages with less complications compared to open and laparoscopic surgery.
Case presentation: We report a 33-year-old male patient who was admitted to our department complaining of abdominal fullness for 20 days. A huge submucosal tumor at the esophagogastric junction was found by upper gastrointestinal endoscopy. We successfully resected the lesion through endoscopic submucosal excavation without complications, which was pathologically confirmed to be a GIST. The patient was discharged 5 days after operation and has been doing well, and there was no recurrence 8 months after the operation.
Conclusion: ESE is possibly an effective and minimally invasive method of giant esophagogastric junction stromal tumor.
Keywords: Case report; Endoscopic submucosal excavation; Esophagogastric junction; Gastrointestinal stromal tumor.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




References
-
- Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004;364(9440):1127–1134. doi: 10.1016/S0140-6736(04)17098-0. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources